Most Awaited Q3 Sale is back. Upto 30% discount on every report.

Medical Device Outsourcing Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 March 16
SKU : MD1185
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Medical Device Outsourcing Market is segmented By Product (Raw Materials, Electronics, and Finished Goods), By Device Type (Class I, II, and III Devices), By Application (Orthopedic & Spine, Cardiovascular, Radiology, and General Medical Devices), By Service (Prototype Development, Finished Device Manufacturing, Assembly & Packagingand, Testing & Regulatory Support Services), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030


Medical Device Outsourcing Market Overview

[150 Pages Report] Medical Device Outsourcing Market size was valued at US$ 112,578.91 million in 2022 and is estimated to reach US$ 289,768.64 million by 2030, growing at a CAGR of 13.26% during the forecast period (2023-2030). Outsourcing is a practice usually undertaken by companies as a cost-cutting measure by hiring a party outside a company to perform services and create goods. The medical device industry is outsourcing both the manufacturing of medical devices and associated services; outsourcing can help equipment manufacturers to accelerate their time to market for a new product and speed up return on investment.

Medical Device Outsourcing Market Summary and Scope



Market CAGR


Segments Covered

By Product, By Device Type, By Application, By Service, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America


To Get a Free Sample Click here


Medical Device Outsourcing Market Dynamics and Trends

The major factors driving the global medical device outsourcing market are the rising incidence of chronic diseases such as cardiovascular, the increasing number of manufacturing facilities, reducing operational costs and the rising demand for outsourcing.

Expanding manufacturing facilities and reducing operational costs are expected to drive the market’s growth.

The medical device outsourcing market is driven by rising demand for advanced products and the trend of offshoring. This growth would be mainly led by the need to curb the rising cost of medical equipment and, thereby, healthcare expenses. An increase in pressure on the manufacturers to reduce the overhead expenses and operational costs while maintaining the quality of healthcare services is propelling the medical device outsourcing market. Product outsourcing helps in reducing production costs by 10-15%.

Additionally, the growing demand for quality healthcare is one of the key factors driving the global medical devices outsourcing market growth. The quality of healthcare delivered depends on the quality of diagnostic devices. This forces device manufacturers to outsource product development to stay ahead in the competitive healthcare industry.

Another driving factor for the medical device outsourcing market is various novel product launches and facility expansion. For instance, in Aug 2022, WuXi STA, a contract research development and manufacturing organization (CRDMO), announced its pharmaceutical manufacturing campus in Delaware, United States. A second facility in the United States to meet the demand of customers.

The threat of losing confidential information is expected to hamper the market growth.

However, the threat of losing confidential information in contracting with a third party for manufacturing, product designing, prototyping, and others is hampering the global medical device outsourcing market.

COVID-19 Impact Analysis on Medical Device Outsourcing Market

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The medical device outsourcing market has experienced huge profits due to the increase in demand for novel and effective vaccines and drugs and the rise in the number of clinical trials. Various biopharmaceutical companies partnered or collaborated with contract research organizations to meet the demands and growing R&D activities. Various initiatives, collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, in Jul 2022, Medidata announced their partnership expansion and renewal with Novotech to continue clinical studies in different therapeutic areas. Leveraging various technologies such as Rave EDC, Ecoa, Rave RTSM etc., from Medidata, Novotech now has equipped tools that are configurable and flexible and address clinical research needs at a large scale.

Medical Device Outsourcing Market Segmentation Analysis

The services segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The services segment is the highest market holder in the global medical device outsourcing market. Based on the services segment, the contract device manufacturing sub-segment holds the largest market share. The need for contract manufacturing is increasing with the need for reducing operational costs and overhead expenses with good quality services.

Manufacturers require high-quality safety gadgets, and the rising manufacturing complexity makes contract manufacturing a better choice. Furthermore, during medical device development, inspection level is getting high, resulting in multiple standards and regulations, leading to increased demand for contract device manufacturing.

The service segment dominates the market due to the rising demand for contract manufacturing and rising global incidences of chronic diseases such as cardiovascular and neurological disorders. The growing number of regulatory approvals, technological advancements, expansion, and research/clinical trial studies drive the market’s growth. For instance, in Aug 2022, Plexus Corp., a product design, manufacturing and marketing services provider, announced its novel manufacturing facility opening in Bangkok, Thailand. Around $60 million is invested in constructing a 400,000 sq. ft. site. This facility will strengthen energy-efficient operational and monitoring systems supporting Plexus’s environmental, social and governance mission (ESG) for the betterment of the world.

Medical Device Outsourcing Market Geographical Share

North America holds the largest market share in the global medical device outsourcing market.

North America dominates the global medical device outsourcing market, primarily attributed to the rising number of chronic disorders, such as cardiac and neurological. According to WHO, it was estimated that coronary artery disease (CAD) was responsible for a total of 11.1 million deaths globally in 2020.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market’s growth in this region. The presence of a large number of medical device manufacturers and the availability of advanced healthcare systems and manufacturing hubs for high-end, consistent, and complex medical devices in this region are contributing to the growth of the medical device outsourcing market.

Moreover, the growing number of product launches is responsible for the market’s growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Apr 2022, Integer Holdings Corporation acquired Connemara Biomedical Holdings Teoranta along with its subsidiaries (Aran Biomedical & Proxy Biomedical). Aran is a high-precision biomaterial coating and advanced metal and polymer manufacturer for and provides solutions for implantable medical devices developing and manufacturing.

Medical Device Outsourcing Companies and Competitive Landscape

The medical device outsourcing market is moderately competitive with local and global companies’ presence. Integer Holdings Corporation, Thermo Fisher Scientific, Nortech Systems, Inc., Plexus Corp., West Pharmaceutical Services, Inc, Celestica, Inc, Intertek Group, Wuxi Apptec, IQVIA Holdings, Benchmark Electronic Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in Apr 2021, IQVIA Holdings Inc., technology solutions, analytical and clinical research service provider, announced that it completely acquired Q2 Solutions, a clinical laboratory services organization, from Quest Diagnostics, a diagnostic information service provider. It already acquired 60% of the shares and now has acquired the remaining 40% of the minority shares resulting in 100% IQVIA’s ownership.

Integer Holdings Corporation.

Overview: Integer Holdings is a medical device outsourcing company that serves various markets, such as cardiac, vascular, neuromodulation and portable medical markets. It provides a novel, innovative technologies with high quality to the medical device industry. It was established in 1940 and is headquartered in Texas, United States.

Product Portfolio:

QHR high-rate primary cells: These are commonly used for treating tachycardia in cardiac rhythm devices and for giving effective therapy in other implantable applications that need pulse currents of ampere-level. This QHR hybrid cathode technology is specially designed to provide high device performance and longevity in a small size.

Key Development: In Dec 2021, Integer Holdings Corporation, a manufacturer of medical device outsourcing, announced that it had completely acquired Oscor, Inc., a private company designing, developing and producing a portfolio of highly specific implantable devices, medical devices, and diagnostic catheters.

The global medical device outsourcing market report would provide access to approx. 45+market data table, 40+figures and 200 (approximate) pages.

Trending Topics

Medical Bionics Market

Infant Incubator Market

Electrosurgical Devices Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version
What is the Projected CAGR value of the Medical Device Outsourcing Market?
Medical Device Outsourcing Market is expected to grow at a CAGR of 13.26% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Medical Device Outsourcing Market during 2023-2030.
Which is the fastest growing region in the Medical Device Outsourcing Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.